Morphoceuticals
Jacqueline Jeha is responsible for operational management and supporting the company's strategic planning processes and building relationships with key stakeholders.
With nearly 15 years of experience in the industry, Jacqueline has held various roles in Clinical Operations. She has global experience in the biopharmaceutical industry encompassing clinical, regulatory, and business development activities. She has had a primary focus on Rare Diseases and Oncology. Prior to joining LyGenesis, Jacqueline held the Associate Director of Clinical Operations role at Karyopharm Therapeutics where she led their Ph3 study to FDA approval.
Jacqueline earned her Master’s in Public Health from Brown University and her Bachelor of Science in Microbiology and Chemistry from the University of Rhode Island.
This person is not in any teams
This person is not in any offices
Morphoceuticals
Morphoceuticals Inc. is a biotechnology company co-founded by Drs. Levin and Kaplan and funded by Juvenescence Ltd. Morphoceuticals is pioneering bioelectric approaches to access anatomical programming that is a core component of our biological operating system. Using proprietary combinations of ion channel and gap junction modulators, we are focused on inducing limb regeneration, improving amputation stump health, promoting organ regeneration, and the treatment of channelopathies.